Trademark
Full logoAbout Gilead Sciences
Gilead Sciences is a biopharmaceutical company best known for its leadership in HIV treatment (Biktarvy, Descovy, Genvoya) and liver disease, plus a growing oncology franchise built around Trodelvy and the Kite Pharma cell-therapy unit (Yescarta, Tecartus). Founded in 1987 and headquartered in Foster City, California, the company developed sofosbuvir and the Harvoni/Epclusa hepatitis C cure that transformed treatment for that disease in the mid-2010s. Gilead's HIV franchise treats more than 80% of U.S. patients and remains one of the most profitable in pharma. The company has been investing heavily in oncology to diversify beyond HIV.
About the Gilead Sciences logo
The Gilead Sciences (GILD) logo is part of the Tickericons pack — a hand-crafted set of logos for every company in the S&P 500. Each logo is manually redrawn to a consistent grid, weight, and corner radius so GILD sits cleanly next to other tickers in cap tables, dashboards, equity research, and fintech UI.
You get two styles: the trademark (just the symbol, ideal for grids and tight UI) and the full logo (mark plus wordmark, ideal when there's room to breathe). Both ship as scalable SVG, high-resolution PNG, and reusable Figma components.
Gilead Sciences was added to the S&P 500 on Jul 1, 2004 and is currently classified under the Health Care sector.
Other Health Care companies
See all →
abtAbbott LaboratoriesMar 4, 195725,279
abbvAbbVieDec 31, 20124,888
aAgilent TechnologiesJun 5, 20009,480
algnAlign TechnologyJun 19, 20173,257
amgnAmgenJan 2, 199212,557
baxBaxter InternationalSep 30, 197219,590
bdxBecton Dickinson and CoSep 30, 197219,590
techBio-Techne CorporationAug 30, 20211,724
biibBiogenNov 13, 20038,224
bsxBoston Scientific CorporationFeb 24, 199511,408
Get all S&P 500 logos
One-time payment. SVG, PNG, and a Figma library. Free updates as the index changes.